National Bank of Canada’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.76K Buy
95
+77
+428% +$5.26K ﹤0.01% 2419
2025
Q4
$1.06K Sell
18
-2,848
-99% -$155K ﹤0.01% 2622
2025
Q3
$158K Sell
2,866
-65
-2% -$3.38K ﹤0.01% 1626
2025
Q2
$126K Buy
+2,931
New +$113K ﹤0.01% 1718
2023
Q3
Sell
-33
Closed -$1.92K 2850
2023
Q2
$1.92K Hold
33
﹤0.01% 2475
2023
Q1
$2.36K Sell
33
-66
-67% -$5.24K ﹤0.01% 2415
2022
Q4
$6.97K Hold
99
﹤0.01% 2259
2022
Q3
$6K Hold
99
﹤0.01% 2310
2022
Q2
$6K Hold
99
﹤0.01% 2387
2022
Q1
$6K Hold
99
﹤0.01% 2512
2021
Q4
$7K Buy
+99
New +$7.53K ﹤0.01% 2466

Other funds holding NGVT

National Bank of Canada's NGVT Position: Q1 2026 in Review

National Bank of Canada increased its Ingevity (NGVT) stake by 428% in Q1 2026, buying an estimated $5.26K and bringing the position to 95 shares worth $6.76K. The position accounts for ﹤0.01% of the portfolio, ranked #2419.

National Bank of Canada first reported a position in NGVT in Q4 2021 and has held it in 11 quarters since. The position peaked at $158K in Q3 2025. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • National Bank of Canada held 95 shares of Ingevity worth $6.76K as of Q1 2026.
  • National Bank of Canada bought 77 Ingevity shares in Q1 2026, an estimated $5.26K.
  • Ingevity made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2419 holding.
  • National Bank of Canada first reported a position in Ingevity in Q4 2021 and has held it in 11 quarters since.
  • National Bank of Canada's Ingevity position peaked at $158K in Q3 2025.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.